Schreiner, A. Et Al. 2012. Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.4 , 449-457.

Schreiner, A., Niehaus, D., Shuriquie, N. A., Aadamsoo, K., Korcsog, P., Salinas, R., ... Theodoropoulou, P.(2012). Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.4, 449-457.

Schreiner, Andreas Et Al. "Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial," JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.4, 449-457, 2012

Schreiner, Andreas Et Al. "Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial." JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.4, pp.449-457, 2012

Schreiner, A. Et Al. (2012) . "Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial." JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.4, pp.449-457.

@article{article, author={Andreas Schreiner Et Al. }, title={Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial}, journal={JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY}, year=2012, pages={449-457} }